HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria.

Abstract
Liver transplantation (LTX) corrects the enzymatic defect responsible for type 1 primary hyperoxaluria (PH1). It has been advocated in combination with kidney transplantation (KTX) in patients with renal failure from PH1 because KTX alone can result in early graft loss. A 58-year-old male patient with PH1 on hemodialysis underwent resection of the left lateral segment of the liver followed by orthotopic auxiliary left lateral segment liver transplantation and kidney transplantation from a deceased donor. The serum oxalate dropped from 34.8 micromol/L before transplant to 3.6-8.3 in the first months posttransplant to <1 micromol/L (normal range 0.4-3.0). One year after posttransplant, the patient has an iothalamate glomerular filtration rate of 58 ml/min. Orthotopic auxiliary LTX is an alternative to whole LTX in PH1. By using a split deceased donor liver, it does not deprive the donor pool and protects the recipient from liver failure in case of graft loss.
AuthorsNicholas Onaca, Edmund Q Sanchez, Larry B Melton, George J Netto, Karl A Glastad, Patriciu A Martin, Takehisa Ueno, Marlon F Levy, Robert M Goldstein, Goran B Klintmalm
JournalTransplantation (Transplantation) Vol. 80 Issue 3 Pg. 421-4 (Aug 15 2005) ISSN: 0041-1337 [Print] United States
PMID16082341 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Oxalates
  • Transaminases
  • Alanine-glyoxylate transaminase
Topics
  • Cadaver
  • DNA Mutational Analysis
  • Glomerular Filtration Rate
  • Graft Rejection
  • Graft Survival
  • Humans
  • Hyperoxaluria, Primary (therapy)
  • Kidney Transplantation (methods)
  • Liver (anatomy & histology, pathology)
  • Liver Transplantation (methods)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Oxalates (blood)
  • Renal Dialysis
  • Time Factors
  • Tissue Donors
  • Transaminases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: